Oral hypoglycemic agents market to reach $75.62 billion by 2030 at 4.9% cagr, driven by rise in type 2 diabetes prevalence.
Read More
Oral contraceptive pills market to reach $61.05 billion by 2030 at 15.0% cagr, driven by rising healthcare expenditure.
Read More
Oral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read More
Plasma fractionation market to reach $55.85 billion by 2030 at 10.4% CAGR, driven by increasing number of chronic diseases.
Read More
Plant-based vaccines market to reach $3.06 billion by 2030 at 11.3% CAGR, driven by high prevalence of infectious diseases.
Read More
Plant-based protein supplements market to reach $6.16 billion by 2030 at 11.0% CAGR, driven by growing vegan population.
Read More
Plant-based active pharmaceutical ingredients (api) market to reach $44.05 billion by 2030 at 6.5% CAGR, driven by growing consumer preference for natural and organic products.
Read More
Pimozide tablet market to reach $2.91 billion by 2030 at 9.5% CAGR, driven by rising prevalence of psychiatric disorders and increased pharmaceutical manufacturing investment.
Read More
Phytogenic feed additives market to reach $1.71 billion by 2030 at 7.9% CAGR, driven by growth of the animal feed industry.
Read More
Phytoestrogen supplements market to reach $6.47 billion by 2030 at 8.3% CAGR, driven by increasing focus on health and fitness.
Read More